Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$17,796,484
+$903,166 QoQ
Shares Held
70,722
-9.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#666
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Linscomb Wealth, Inc. holds $62,600,297 across 7 Drug Manufacturers - General names. ABBV ranks #1 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
70,722 | $17,796,484 | |
| 2 | JNJ |
Johnson & Johnson
|
59,468 | $15,103,087 | |
| 3 | MRK |
Merck & Co., Inc.
|
92,395 | $11,872,757 | |
| 4 | AMGN |
Amgen Inc
|
29,620 | $10,725,994 | |
| 5 | PFE |
Pfizer Inc
|
209,174 | $5,036,909 | |
| 6 | LLY |
ELI LILLY & Co
|
1,056 | $1,266,598 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,320 | $798,468 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,796,484 | 70,722 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $16,893,318 | 77,674 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $19,986,020 | 87,470 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $20,539,913 | 88,710 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $16,736,427 | 90,165 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $18,277,896 | 87,237 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $13,933,634 | 78,411 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $15,475,125 | 78,363 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $13,895,864 | 81,016 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $14,789,433 | 81,216 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $12,968,044 | 83,681 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $12,786,813 | 85,783 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $12,146,044 | 90,151 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $15,065,246 | 94,530 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $16,069,205 | 99,432 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,644,460 | 94,214 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $14,503,945 | 94,698 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $16,450,922 | 101,480 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $13,429,649 | 99,185 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $10,599,629 | 98,263 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $10,864,578 | 96,454 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $10,147,248 | 93,765 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $9,935,912 | 92,729 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $7,931,800 | 90,556 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,568,070 | 87,269 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $5,796,916 | 76,085 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||